Atıf Formatları
Development of hepatocellular carcinoma in patients with chronic hepatitis C who had sustained viral response following direct-acting antiviral therapy
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Ebik Et Al. , "Development of hepatocellular carcinoma in patients with chronic hepatitis C who had sustained viral response following direct-acting antiviral therapy," HEPATOLOGY FORUM , vol.3, no.3, pp.82-87, 2022

Ebik, B. Et Al. 2022. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had sustained viral response following direct-acting antiviral therapy. HEPATOLOGY FORUM , vol.3, no.3 , 82-87.

Ebik, B., Aygan, M., Tuncel, E. T., Kacmaz, H., Ekin, N., ARPA, M., ... YALÇIN, K.(2022). Development of hepatocellular carcinoma in patients with chronic hepatitis C who had sustained viral response following direct-acting antiviral therapy. HEPATOLOGY FORUM , vol.3, no.3, 82-87.

Ebik, Berat Et Al. "Development of hepatocellular carcinoma in patients with chronic hepatitis C who had sustained viral response following direct-acting antiviral therapy," HEPATOLOGY FORUM , vol.3, no.3, 82-87, 2022

Ebik, Berat Et Al. "Development of hepatocellular carcinoma in patients with chronic hepatitis C who had sustained viral response following direct-acting antiviral therapy." HEPATOLOGY FORUM , vol.3, no.3, pp.82-87, 2022

Ebik, B. Et Al. (2022) . "Development of hepatocellular carcinoma in patients with chronic hepatitis C who had sustained viral response following direct-acting antiviral therapy." HEPATOLOGY FORUM , vol.3, no.3, pp.82-87.

@article{article, author={Berat Ebik Et Al. }, title={Development of hepatocellular carcinoma in patients with chronic hepatitis C who had sustained viral response following direct-acting antiviral therapy}, journal={HEPATOLOGY FORUM}, year=2022, pages={82-87} }